Text Size
148 studies found for:    Cerebral Atrophy

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Cerebral Atrophy
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results 		A Clinical Study Evaluating the Effects of Memantine on Brain Atrophy in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Memantine;   Drug: Placebo
2 Completed Influence of Age on Amyloid Load in Alzheimer's Disease and in Atypical Focal Cortical Alzheimer's Disease
Conditions: Alzheimer's Disease;   Posterior Cortical Atrophy;   Logopenic Progressive Aphasia
Intervention:
3 Active, not recruiting Sunphenon in Progressive Forms of Multiple Sclerosis
Condition: Primary or Secondary Chronic-progressive Multiple Sclerosis
Interventions: Drug: Sunphenon EGCG;   Drug: Placebo
4 Completed A Longitudinal Study of Brain Atrophy in MS Patients Over 5 Years
Condition: Multiple Sclerosis
Intervention:
5 Active, not recruiting Evaluation of Brain Atrophy in CIS Patients on Avonex
Condition: Multiple Sclerosis
Intervention:
6 Recruiting Double Blind Placebo-Controlled Phase I/II Clinical Trial of Idebenone in Patients With Primary Progressive Multiple Sclerosis (IPPoMS)
Condition: Primary Progressive Multiple Sclerosis
Intervention: Drug: Idebenone
7 Recruiting Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis
Conditions: Autoimmune Diseases of the Nervous System;   Multiple Sclerosis;   Secondary Progressive Multiple Sclerosis;   Disease Progression;   Brain Atrophy
Interventions: Biological: Tcelna;   Biological: Placebo
8 Recruiting Evaluating the Impact of Cerebral Ischemic And Degenerative Changes On Cognition
Condition: Cognitive Decline
Intervention:
9 Active, not recruiting ACCORD-MIND: Action to Control Cardiovascular Risk in Diabetes--Memory in Diabetes
Conditions: Atherosclerosis;   Cardiovascular Diseases;   Hypercholesterolemia;   Hypertension;   Diabetes Mellitus;   Coronary Disease
Interventions: Drug: hypoglycemic agents;   Drug: hydroxymethylglutaryl-CoA Reductase inhibitors;   Drug: antihypertensive agents;   Drug: fibrates
10 Completed Investigation of Simvastatin in Secondary Progressive Multiple Sclerosis
Condition: Secondary Progressive Multiple Sclerosis
Interventions: Drug: Simvastatin;   Drug: Placebo
11 Unknown † Gait and Alzheimer Interaction Tracking (GAIT) Study
Conditions: Gait Apraxia;   Alzheimer Disease;   Impaired Cognition;   Cerebral Atrophy
Intervention:
12 Recruiting Fingolimod Versus Interferon Beta 1b in Cognitive Symptoms
Condition: Multiple Sclerosis
Interventions: Drug: Fingolimod;   Drug: Interferon beta 1b
13 Completed Fatigue in Multiple Sclerosis: Evaluated With 3 MRI and Transcranial Magnetic Stimulation
Conditions: Multiple Sclerosis;   Fatigue
Interventions: Drug: 3,4-diaminopyridine;   Drug: Placebo
14 Unknown † A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Avonex and Topamax
15 Completed Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease)
Condition: Alzheimer's Disease
Intervention: Drug: memantine HCl
16 Recruiting Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe)
Condition: Multiple Sclerosis
Intervention: Drug: Rituximab
17 Recruiting Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD
Conditions: Atypical Alzheimers Disease;   Logopenic Variant of Primary Progressive Aphasia (LPA);   Posterior Cortical Atrophy (PCA)
Intervention: Drug: C-11 PiB
18 Recruiting Effects of EGCG (Epigallocatechin Gallate) in Huntington's Disease (ETON-Study)
Condition: Huntington Disease
Interventions: Drug: (2)-epigallocatechin-3-gallate (EGCG);   Drug: Placebo
19 Completed Efficacy, Safety and Tolerability of Atorvastatin 40 mg in Patients With Relapsing-remitting Multiple Sclerosis Treated With Interferon-beta-1b
Condition: Relapsing-remitting Multiple Sclerosis
Interventions: Drug: Interferon beta-1b group;   Drug: Interferon beta-1b/Atorvastatin group
20 Enrolling by invitation Long-Term Extension Study in Subjects With Multiple Sclerosis Who Have Completed Study 205MS301 (NCT01064401) to Evaluate the Safety and Efficacy of DAC HYP
Conditions: Multiple Sclerosis, Relapsing-Remitting;   Multiple Sclerosis
Intervention: Drug: DAC HYP
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years